US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Northwest Biotherapeutics, Inc.

0.2598

+0.00883.51%

Volume:2.44M

Turnover:623.68K

Market Cap:390.10M

PE:-2.93

High:0.2647

Open:0.2572

Low:0.2500

Close:0.2510

52wk High:0.4788

52wk Low:0.1685

Shares:1.50B

Float Shares:1.38B

Volume Ratio:0.71

T/O Rate:0.18%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0888

EPS(LYR):-0.0575

ROE:276.45%

ROA:-141.48%

PB:-3.89

PE(LYR):-4.52

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Northwest Biotherapeutics, Inc.

Exchange:

OTCQB

Establishment Date:

1996

Employees:

25

Office Location:

4800 Montgomery Lane,Suite 800,Bethesda,Maryland,United States

Website:

http://www.nwbio.com

Zip Code:

20814

Phone:

Fax:

- -

Introduction:

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NWBO/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NWBO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","market":"US","secType":"STK","nameCN":"Northwest Biotherapeutics, Inc.","latestPrice":0.2598,"timestamp":1757707200000,"preClose":0.251,"halted":0,"volume":2436454,"delay":15,"floatShares":1381857805,"shares":1501533138,"eps":-0.08878,"marketStatus":"Market Closed","change":0.0088,"latestTime":"09-12 16:00:00 EDT Delay","open":0.2572,"high":0.2647,"low":0.25,"amount":623684.9161500019,"amplitude":0.058566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.08878,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1757923200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.251,"volumeRatio":0.7140844078255011},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NWBO\",,,,,undefined,":{"symbol":"NWBO","floatShares":1381857805,"roa":"-141.48%","roe":"276.45%","lyrEps":-0.057517,"volumeRatio":0.7140844078255011,"shares":1501533138,"dividePrice":0,"high":0.2647,"amplitude":0.058566,"preClose":0.251,"low":0.25,"week52Low":0.16845,"pbRate":"-3.89","psRate":"356.58","week52High":0.4788,"institutionHeld":0.001,"latestPrice":0.2598,"eps":-0.08878,"divideRate":0,"volume":2436454,"delay":15,"ttmEps":-0.08878,"open":0.2572,"prevYearClose":0.27475,"prevWeekClose":0.2526,"prevMonthClose":0.301,"prevQuarterClose":0.2399,"fiveDayClose":0.2526,"twentyDayClose":0.2376,"sixtyDayClose":0.2686},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NWBO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-10","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-05","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709614800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-09","symbol":"NWBO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699506000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NWBO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1342115,"yearFounded":1996,"employeeNum":25,"address":"4800 Montgomery Lane,Suite 800,Bethesda,Maryland,United States","zipCode":"20814","officePhone":"240 497 9024"},"stockCompanyDetail":{"websiteUrl":"http://www.nwbio.com","stockEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":-0.1296},{"period":"3month","weight":-0.0208},{"period":"6month","weight":-0.2047},{"period":"1year","weight":0.2368},{"period":"ytd","weight":0.1436}],"description":"Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.","exchange":"OTCQB","name":"Northwest Biotherapeutics, Inc.","nameEN":"Northwest Biotherapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NWBO\",market:\"US\",,,undefined,":null}}